Paul Thomas

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 1.8K citations

Urology, Surgical Oncology, High-risk Prostate Cancer +12

Modern thirty-day operative mortality for surgical resections in lung cancer

Robert J. Ginsberg, Lucius D. Hill, Robert T. Eagan et al. · Journal of Thoracic and Cardiovascular Surgery · 1983 · 654 citations

Surgical Oncology, Medicine, Bronchial Neoplasm +6

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

Richard J. McManus, Jonathan Mant, Marloes Franssen et al. · The Lancet · 2018 · 405 citations · Full text

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

Louise Emmett, James P Buteau, Nathan Papa et al. · European Urology · 2021 · 394 citations

Additive Diagnostic Value, Urology, Medical Imaging +8

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10